EyeMacular Regeneration, Inc.
Biotechnology company · St. Paul, Minnesota, United States
EyeMacular Regeneration, Inc. is a biotechnology company headquartered in St. Paul, Minnesota, United States. Its earliest recorded incorporation is in 2023. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $382,493 in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $2 million sold in a notice filed in 2025.
EyeMacular Regeneration at a glance
What does EyeMacular Regeneration do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $382,493 in total (2019). NIH funding came from the National Eye Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $2 million sold (2025).
Frequently asked questions about EyeMacular Regeneration
Where is EyeMacular Regeneration headquartered?
EyeMacular Regeneration, Inc. is headquartered in St. Paul, Minnesota, United States.
What does EyeMacular Regeneration do?
EyeMacular Regeneration, Inc. is a biotechnology company.
When was EyeMacular Regeneration founded?
The earliest incorporation on record for EyeMacular Regeneration, Inc. is in 2023, according to public company registers.
Similar companies
- Agitated Solutions, Inc.Saint Paul, Minnesota, United States
- Astrin Biosciences, Inc.Saint Paul, Minnesota, United States
- Myogenica Inc.Saint Paul, Minnesota, United States
- B-MoGen Biotechnologies, Inc.Saint Paul, Minnesota, United States
- Aria CV, Inc.Saint Paul, Minnesota, United States
- Innovative Surface Technologies IncSaint Paul, Minnesota, United States
- Quench Medical Inc.Saint Paul, Minnesota, United States
- Marpam Pharma LLCSaint Paul, Minnesota, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences